KEITH WEBBER, Ph.D., OF CBER, FDA TO PRESENT AT IBC LIFE SCIENCES 10TH ANNUAL ANTIBODY PRODUCTION & DOWNSTREAM PROCESSING EVENT
IBC's Antibody Production & Downstream Processing is celebrating 10 years of providing superior content and networking to the Biopharmaceutical industry. It has announced that Keith Webber, of CBER and FDA will present the Keynote Address at this meeting to be held on March 5-7, 2003 at the Hilton La Jolla Torrey Pines in La Jolla, CA. Co-Located with Process Validation for Biologicals and Antibody Partnering & Collaboration both held March 3-4, 2003, this 10 year celebration will provide the top notch presenters a venue to discuss the essentials for producing therapeutic antibodies and learn how to maximize production efficiency. The meeting is expected to surpass its previous year's attendance of over 500 attendees and over 40 exhibit booths. Keith Webber, Director, Division of Monoclonal Antibodies, Office of Therapeutic Research and Review, CBER, FDA will present the Keynote Address on FDA Regulation of Biologics Produced in Bioengineered Plants. Dr. Webber is Chair of the FDA/USDA Interagency Working Group that has recently published a draft Guidance for Industry on drugs, biologics, and medical devices derived from bioengineered plants for use in humans and animals. The content of the meeting focuses primarily on the most relevant aspects of antibody manufacturing. Some of the highlights will include: � Thomas Harnett revealing the design considerations for start-up and operation of Centocor's new Malvern, PA Facility � Greg Blank of Genentech discussing the criteria for what makes a good manufacturing process within the context of high volume production � Brian Hubbard of Amgen divulging the changes implemented to the approved commercial process for manufacture of Enbrel� � Lynn Conley of IDEC Pharmaceuticals detailing the challenges encountered with developing the purification and conjugation process for Zevalin � Reed Harris of Genentech delivering new data about the impact of c glycans on the clearance of XolairTM For more information on attending Antibody Production & Downstream Processing in La Jolla, March 5-7, 2003, visit http://www.lifesciencesinfo.com/antibodyprod Or call 508-616-5550, X1004 ******************************************************** This segmented email list tends to serve the people who are interested in news and product info in Proteomics sector. To edit or change your interest category selections or unsubscribe,simply reply to this email. To distribute your releases to this list, contact [EMAIL PROTECTED] BIOTAQ.COM's email news service is focused exclusively on biotech industry. Welcome to join BIOTAQ.COM at: http://www.biotaq.com/Joinbiotaq.htm ************************************************************************** ** _______________________________________________ Biojava-l mailing list - [EMAIL PROTECTED] http://biojava.org/mailman/listinfo/biojava-l
